-Approximately 500 Canadians ages 6-11 are now eligible for TRIKAFTA®-
-Vertex has submitted this indication to CADTH & INESSS for Health Technology Assessments-
. | April 20, 2022
Kaftrio® with ivacaftor approved by EC to treat children with cystic fibrosis europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Santhera Announces Positive Results with Lonodelestat in Early Phase Cystic Fibrosis Trial apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.